Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Dec 10, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, providing a consistent and reliable option for managing intraocular pressure (IOP). Differing from traditional eye drops that demand frequent use, iDose® TR is a small, implantable device designed to deliver a controlled medication delivery directly into the eye over an longer period. This cutting-edge approach eliminates the need for frequent dosing, dramatically boosting patient adherence and overall treatment results.

At Eye Center South, we are honored to introduce iDose® TR as part of our comprehensive glaucoma care. The device is implanted during a minimally invasive procedure, designed with your ease in mind. Once in place, it ensures a steady dose of the prescribed medication, working to stabilize intraocular pressure and protect your vision. Patients who have difficulty managing the routine of applying eye drops daily can experience significant advantages from this state-of-the-art treatment.



Visit for more info At Eye Center South